Abstract
Colchicine is derived from the corms of Colchicum autumnale . The drug has been used therapeutically for more than 200 years in the treatment of various diseases such as Gout, Familial Mediterranean Fever (FMF), and Behcet's disease ; yet, its myotoxicity adverse reaction has not only been documented before 1996 in the British National Formulary. Colchicine induced myopathy has been described in patients with chronic renal failure and patients who are using a concomitant drug like a statin. However, pure myopathy caused by Colchicine never been reported from Saudi Arabia.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
